ID: ALA4475998

Max Phase: Preclinical

Molecular Formula: C11H11N3O3

Molecular Weight: 233.23

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COCc1cn(-c2ccc(C(=O)O)cc2)nn1

Standard InChI:  InChI=1S/C11H11N3O3/c1-17-7-9-6-14(13-12-9)10-4-2-8(3-5-10)11(15)16/h2-6H,7H2,1H3,(H,15,16)

Standard InChI Key:  MIKUGZUZRWUAQJ-UHFFFAOYSA-N

Associated Targets(non-human)

ORF 73 309 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 233.23Molecular Weight (Monoisotopic): 233.0800AlogP: 1.11#Rotatable Bonds: 4
Polar Surface Area: 77.24Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.51CX Basic pKa: CX LogP: 1.29CX LogD: -1.51
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.86Np Likeness Score: -1.70

References

1. Kirsch P, Jakob V, Oberhausen K, Stein SC, Cucarro I, Schulz TF, Empting M..  (2019)  Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.,  62  (8): [PMID:30888817] [10.1021/acs.jmedchem.8b01827]

Source